EquityZen Growth Technology Fund LLC - Series 834
Raised
$878K
Investors
45
Min Invest
$10,001
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 834 is a Delaware limited liability company filed by EquityZen Advisors LLC on 2021-05-05, raising $878K from 45 investors under Rule 506(b) and Section 3(c)(1). The vehicle has a $10K minimum investment and is part of EquityZen's pre-IPO investment platform, which operates nearly 1,900 related entities providing access to shares in private growth companies.
This pre-IPO pooled investment fund uses the standard 506(b) private placement exemption combined with 3(c)(1) to remain outside Investment Company Act registration. The $10K minimum investment represents EquityZen's retail-accessible tier, significantly lower than traditional pre-IPO funds, enabling broader participation in private company secondary markets through a serialized SPV structure.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
